# Zenlabs Ethica Ltd (ZENLABS) > Exchange: NSE | Sector: Pharma | ISIN: ## Price Current Price: ₹30.38 Day Change: -0.66% 52W High: ₹39.2 52W Low: ₹16.5 Market Cap: ₹19 Cr ## Valuation P/E: 0 P/B: 1.71 EPS: ₹-2.84 Book Value: ₹16.84 Dividend Yield: 0% ## Returns 1Y Return: -4.76% ## Profitability ROE: 0% ROCE: 0% Debt/Equity: 0 Revenue Growth: 0% Profit Growth: 0% EBITDA Margin: 0% Operating Margin: 0% ## About Zenlabs Ethica Ltd is a Medical Distribution company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Pharma Industry: Medical Distribution Sub Industry: Unknown ## Business Model Overview: Zenlabs Ethica Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Distribution. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance - Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance ## Access Current tier: anonymous More history: Register free to see 1 more year. ## Data Freshness Quote Updated: 2026-05-19T09:00:20.641Z Price History Updated: 2026-05-19T09:00:21.133Z Latest Price History Date: 2026-05-19 Technicals Updated: 2026-05-19T09:00:21.133Z Quant Updated: 2026-05-19T09:00:21.133Z Sentiment Updated: 2026-05-19T09:00:21.133Z Financials Status: current Financials Updated: 2026-05-18T15:30:00.976Z Financials Last Attempt: 2026-05-18T15:30:00.976Z Financials Provider Tried: database Latest P&L Period: FY 2025 Latest Balance Sheet Period: FY 2025 Latest Cash Flow Period: FY 2025 ## P&L (FY 2022) Revenue: ₹69 Cr Operating Profit: ₹2 Cr (OPM 2.18%) Net Profit: ₹1 Cr Tax: ₹0 Cr ## Annual P&L History FY 2022: Rev ₹69Cr | PAT ₹1Cr | OPM 2.18% FY 2023: Rev ₹67Cr | PAT ₹0Cr | OPM 2.48% FY 2024: Rev ₹59Cr | PAT ₹0Cr | OPM 1.91% ## Balance Sheet (FY 2022) Total Assets: ₹38 Cr Total Liabilities: ₹29 Cr Borrowings: ₹4 Cr Cash: ₹undefined Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% --- Source: rupiya.io/stocks/zenlabs Disclaimer: For research and education only. Not investment advice.